Live News NEWS FLASH L impact Sep 23, 2026, 11:30 AM UTC WVE - Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity WVE SquawkNews Desk